Skip To Main Content
Von Dadelszen P on Muck Rack

Von Dadelszen P

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Von Dadelszen

Contact Von Dadelszen, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Prediction of hypertensive disorders after screening at 35-36 weeks' gestation: comparison of angiogenic markers with competing-risks model

|
By Magee LA, Nicolaides KH, Von Dadelszen P
| ncbi.nlm.nih.gov
Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software
Open in Who Shared View Duplicates (630) Issue with article?

Interventions affecting the nitric oxide pathway versus placebo or no therapy for fetal growth restriction in pregnancy

|
By Kenny LC, Baker PN, Von Dadelszen P, Kariya CT
| ncbi.nlm.nih.gov
Anouk Pels and Wessel Ganzevoort performed the assessment and data extraction of the studiesSharp 2018, Groom 2019 and von Dadelszen 2022. Aris Papageorghiou and Katie Groom performed the assessment and data extraction of Pels 2020. Anouk Pels: was involved in the Dutch STRIDER trial, a randomised controlled trial investigating sildenafil versus placebo in severe, early‐onset fetal growth restriction. The Dutch STRIDER trial was eligible for inclusion in the systematic review.
Open in Who Shared Issue with article?
See all 2 articles